Active

Lira Pharma

Switched

BE0685498505

Rechtspersoon Private limited company 1 establishment

Astridplein 70, 2280 Grobbendonk Activiteiten van holdings

Active for

8 year, 9 months

Financials

Financial year 2025

Gross margin

€ 330,551

▲ 10% vs 2024

Profit

Growing

€ 210,951

▲ 13% vs 2024

Debts

Low

€ 1.3 million

▼ 12% vs 2024

Lira Pharma from Grobbendonk, company number BE0685498505, closed financial year 2025 with a result of € 210,951 after tax. For that financial year Lira Pharma recorded a gross margin of € 330,551 and equity of € 1.4 million. Compared with financial year 2024, the result moved from € 186,965 to € 210,951. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 18, 2026.

What happened at Lira Pharma?

What happened at Lira Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 210,951 (▲ 13% vs 2024). filed late Source: NBB ↗
  • New establishment in Grobbendonk. KBO
  • Start of the company according to the CBE. KBO
  • Raf Maria Louis Sempels became a director. NBB
  • Linde Maria-Johanna Hugo Stegen became a director. NBB

In short

From € 176,290 profit in 2021 to € 210,951 profit in 2025.

Paid € 421,659 in corporate taxes since 2021.

Best year ever: 2022, with € 213,076 profit.

A new publication or filing at Lira Pharma? We notify you, reason included.

Follow Lira Pharma

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Raf Maria Louis Sempels
Linde Maria-Johanna Hugo Stegen
Lira Pharma

Behind Lira Pharma are Raf Maria Louis Sempels and Linde Maria-Johanna Hugo Stegen. It owns 100% of Apotheek Stegen itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Raf Maria Louis Sempels

Director

since 2017

Linde Maria-Johanna Hugo Stegen

Director

since 2017

Establishments

Establishment units

Physical locations of this company

Registered office

Astridplein 70

2280 Grobbendonk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0685.498.505
VAT number
BE 0685.498.505
Registered office
Astridplein 70, 2280 Grobbendonk
Names & denominations
Lira Pharma
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
30 November 2017
Peppol
Active · Active since 4 Dec 2025
Activities · NACE

Activiteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of Lira Pharma?
The enterprise number of Lira Pharma is BE0685498505.
What is the address of Lira Pharma?
The registered office of Lira Pharma is located at Astridplein 70, 2280 Grobbendonk.
When was Lira Pharma founded?
Lira Pharma was founded on 30 November 2017.
What is the main activity of Lira Pharma?
The main activity of Lira Pharma is "Activiteiten van holdings" (NACE code 64210).
Does Lira Pharma have a website?
No website is currently known for Lira Pharma.
How much profit did Lira Pharma make in 2025?
Lira Pharma posted a profit after taxes of € 210,951 in financial year 2025.
What is the revenue of Lira Pharma?
As a small company, Lira Pharma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 330,551.
Where can I find the annual accounts of Lira Pharma?
Lira Pharma files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Lira Pharma?
According to the 2025 annual accounts, the directors of Lira Pharma are: Raf Maria Louis Sempels, Linde Maria-Johanna Hugo Stegen.
Who owns Lira Pharma?
Behind Lira Pharma are Raf Maria Louis Sempels and Linde Maria-Johanna Hugo Stegen. It owns 100% of Apotheek Stegen itself.